These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 34663329)

  • 21. The long noncoding RNA HOXA transcript at the distal tip promotes colorectal cancer growth partially via silencing of p21 expression.
    Lian Y; Ding J; Zhang Z; Shi Y; Zhu Y; Li J; Peng P; Wang J; Fan Y; De W; Wang K
    Tumour Biol; 2016 Jun; 37(6):7431-40. PubMed ID: 26678886
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circ-0104631 promotes cell proliferation and invasion in colorectal cancer and predicts poor prognosis.
    Cao JZ; Ma LM; Zhang YL; Guo HC; Niu X; Zhao TB
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4730-4737. PubMed ID: 31210299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Knockdown of tripartite motif 59 (TRIM59) inhibits proliferation in cholangiocarcinoma via the PI3K/AKT/mTOR signalling pathway.
    Shen H; Zhang J; Zhang Y; Feng Q; Wang H; Li G; Jiang W; Li X
    Gene; 2019 May; 698():50-60. PubMed ID: 30822475
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SLC25A22 Promotes Proliferation and Survival of Colorectal Cancer Cells With KRAS Mutations and Xenograft Tumor Progression in Mice via Intracellular Synthesis of Aspartate.
    Wong CC; Qian Y; Li X; Xu J; Kang W; Tong JH; To KF; Jin Y; Li W; Chen H; Go MY; Wu JL; Cheng KW; Ng SS; Sung JJ; Cai Z; Yu J
    Gastroenterology; 2016 Nov; 151(5):945-960.e6. PubMed ID: 27451147
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SEZ6L2 knockdown impairs tumour growth by promoting caspase-dependent apoptosis in colorectal cancer.
    An N; Zhao Y; Lan H; Zhang M; Yin Y; Yi C
    J Cell Mol Med; 2020 Apr; 24(7):4223-4232. PubMed ID: 32105413
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The overexpression of AUF1 in colorectal cancer predicts a poor prognosis and promotes cancer progression by activating ERK and AKT pathways.
    Tian XY; Li J; Liu TH; Li DN; Wang JJ; Zhang H; Deng ZL; Chen FJ; Cai JP
    Cancer Med; 2020 Nov; 9(22):8612-8623. PubMed ID: 33016643
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Silencing of long non-coding RNA SBDSP1 suppresses tumor growth and invasion in colorectal cancer.
    Shi D; Liang L; Zheng H; Cai G; Li X; Xu Y; Cai S
    Biomed Pharmacother; 2017 Jan; 85():355-361. PubMed ID: 27890432
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ACAT2 Promotes Cell Proliferation and Associates with Malignant Progression in Colorectal Cancer.
    Weng M; Zhang H; Hou W; Sun Z; Zhong J; Miao C
    Onco Targets Ther; 2020; 13():3477-3488. PubMed ID: 32425549
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The high expression of long non-coding RNA PANDAR indicates a poor prognosis for colorectal cancer and promotes metastasis by EMT pathway.
    Lu M; Liu Z; Li B; Wang G; Li D; Zhu Y
    J Cancer Res Clin Oncol; 2017 Jan; 143(1):71-81. PubMed ID: 27629879
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HSPA4 Knockdown Retarded Progression and Development of Colorectal Cancer.
    Zhang M; Dai W; Li Z; Tang L; Chen J; Chen C
    Cancer Manag Res; 2021; 13():4679-4690. PubMed ID: 34163243
    [TBL] [Abstract][Full Text] [Related]  

  • 31. lncRNA KCNQ1OT1 knockdown inhibits colorectal cancer cell proliferation, migration and invasiveness via the PI3K/AKT pathway.
    Duan Q; Cai L; Zheng K; Cui C; Huang R; Zheng Z; Xie L; Wu C; Yu X; Yu J
    Oncol Lett; 2020 Jul; 20(1):601-610. PubMed ID: 32565985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways.
    Duan S; Huang W; Liu X; Liu X; Chen N; Xu Q; Hu Y; Song W; Zhou J
    J Exp Clin Cancer Res; 2018 Dec; 37(1):304. PubMed ID: 30518405
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LINC00978 promotes hepatocellular carcinoma carcinogenesis partly via activating the MAPK/ERK pathway.
    Zhang Q; Cheng S; Cao L; Yang J; Wang Y; Chen Y
    Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32077915
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cell division cycle associated 5 promotes colorectal cancer progression by activating the ERK signaling pathway.
    Shen A; Liu L; Chen H; Qi F; Huang Y; Lin J; Sferra TJ; Sankararaman S; Wei L; Chu J; Chen Y; Peng J
    Oncogenesis; 2019 Feb; 8(3):19. PubMed ID: 30808873
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LINC01198 promotes colorectal cancer cell proliferation and inhibits apoptosis via Notch signaling pathway.
    Chen S; Yuan H; Chen BC; Wan ZA; Tu SL; Hu XY
    Eur Rev Med Pharmacol Sci; 2020 Aug; 24(16):8439-8446. PubMed ID: 32894550
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Up-regulation of REG3A in colorectal cancer cells confers proliferation and correlates with colorectal cancer risk.
    Ye Y; Xiao L; Wang SJ; Yue W; Yin QS; Sun MY; Xia W; Shao ZY; Zhang H
    Oncotarget; 2016 Jan; 7(4):3921-33. PubMed ID: 26646797
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LncRNA SNHG6 promotes proliferation, invasion and migration in colorectal cancer cells by activating TGF-β/Smad signaling pathway via targeting UPF1 and inducing EMT via regulation of ZEB1.
    Wang X; Lai Q; He J; Li Q; Ding J; Lan Z; Gu C; Yan Q; Fang Y; Zhao X; Liu S
    Int J Med Sci; 2019; 16(1):51-59. PubMed ID: 30662328
    [No Abstract]   [Full Text] [Related]  

  • 38. Role of MUC20 overexpression as a predictor of recurrence and poor outcome in colorectal cancer.
    Xiao X; Wang L; Wei P; Chi Y; Li D; Wang Q; Ni S; Tan C; Sheng W; Sun M; Zhou X; Du X
    J Transl Med; 2013 Jun; 11():151. PubMed ID: 23787019
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytochrome C Oxidase Assembly Factor 1 Homolog Predicts Poor Prognosis and Promotes Cell Proliferation in Colorectal Cancer by Regulating PI3K/AKT Signaling.
    Xue Y; Li PD; Tang XM; Yan ZH; Xia SS; Tian HP; Liu ZL; Zhou T; Tang XG; Zhang GJ
    Onco Targets Ther; 2020; 13():11505-11516. PubMed ID: 33204105
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Silencing GDI2 inhibits proliferation, migration and invasion of colorectal cancer through activation of p53 signaling pathway.
    Ou WT; Tan RJ; Zhai JW; Sun LJ; Xu FP; Huang XJ; Quan ZH; Zhou CJ
    Heliyon; 2024 Sep; 10(18):e37770. PubMed ID: 39323841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.